Introduction and Objective: KCNK17, which encodes TALK-2, is one of the most abundant β-cell K+ channel transcripts. Polymorphisms in KCNK17 are associated with an increased predisposition for developing T2D. Therefore, our objective was to determine the β-cell functions of TALK-2.

Methods: Localization of TALK-2 was investigated with immunofluorescent staining and TALK-2-GFP constructs. TALK-2 function was tested with Ca2+ imaging of inducible TALK-2 cells, adenoviral KCNK17 shRNA mediated knockdown (KD) of dispersed human islets, and β-cell TALK-2 KD pseudoislets. Insulin secretion was performed with pseudoislets.

Results: TALK-2 protein displayed ER localization in β-cells within human pancreatic sections. Additionally, TALK-2-GFP colocalized with an ER-RFP marker and a plasmalemma dye in HEK293 cells. Overexpression of TALK-2 in HEK293 cells accelerated ER Ca2+ release (by 62±13%), reduced ER Ca2+ storage (by 67±12%) and increased basal cytosolic Ca2+ (by 11±0.5%). In human β-cells TALK-2 KD increased ER Ca2+ storage (by 16±5%). Moreover, TALK-2 KD increased Ca2+ influx at 11mM glucose in human β-cells that were dispersed (by 20±6%) and in pseudoislet preps (by 208±64%). Finally, β-cell TALK-2 KD pseudoislets showed reduced insulin secretion at 1mM (by 36±10%).

Conclusion: These data support that ER and plasmalemma localized TALK-2 channels function to reduce β-cell ER Ca2+ stores and limit glucose-induced Ca2+ influx respectively. Furthermore, TALK-2-mediated augmentation of ER Ca2+ leak likely enhanced basal insulin secretion by increasing cytosolic Ca2+. Therefore, polymorphisms in KCNK17 that increase TALK-2 activity or expression would be predicted to diminish β-cell ER Ca2+ stores, impair glucose-stimulated Ca2+ influx, elevate basal insulin secretion, and thus enhance insulin resistance.

Disclosure

J. Dobson: None. P. Dadi: None. A.Y. Nakhe: None. D. Jacobson: None.

Funding

Initiative for Maximizing Student Development at Vanderbilt (T32GM139800)Multidisciplinary Training in Molecular Endocrinology(T32DK007563); National Institutes of Health (DK-097392)

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.